|
Jay Birnbaum, PhD, is a co-founder of Kythera and served as the initial Chief Medical Officer at Kythera while maintaining an active consulting practice. Prior to consulting, he was Vice President, Global Project Management, at Novartis/Sandoz, where he had global responsibilities for strategic planning and development of the company's dermatology portfolio.
His management and product development experience includes ethical and OTC drugs, devices, cosmetics and toiletries, and spans the areas of drug discovery, formulations, clinical, regulatory, and marketing. He has developed and commercialized products and brands in all facets of dermatology, including Lamisil®, the world's largest dermatology brand of antifungal products, and Skin Caviar, the centerpiece of the upscale LaPrairie Skin Care brand, for over 20 years.
Jay holds a BS in Biology from Trinity College and a PhD in Pharmacology from the University of Wisconsin. He has published extensively on his work in drug development and is on the Science Advisory Board of NanoBio Corporation and on the Board of Directors of Oculus Innovative Sciences, Inc.
| 